| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 17440 | 2017 |
| 2013 ESH/ESC Guidelines for the management of arterial hypertension G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M Böhm, ... Arterial Hypertension 17 (2), 69-168, 2013 | 14709 | 2013 |
| 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and … B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... European heart journal 39 (33), 3021-3104, 2018 | 14052 | 2018 |
| Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document G Mancia, S Laurent, E Agabiti-Rosei, E Ambrosioni, M Burnier, ... Blood pressure 18 (6), 308-347, 2009 | 3148 | 2009 |
| Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of … G Mancia, R Fagard, K Narkiewicz, J Redón, A Zanchetti, M Böhm, ... J hypertens 31 (7), 1281-357, 2013 | 1573 | 2013 |
| Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in … K Wachtell, M Lehto, E Gerdts, MH Olsen, B Hornestam, B Dahlöf, H Ibsen, ... Journal of the American College of Cardiology 45 (5), 712-719, 2005 | 1257 | 2005 |
| A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension MH Olsen, SY Angell, S Asma, P Boutouyrie, D Burger, JA Chirinos, ... The Lancet 388 (10060), 2665-2712, 2016 | 904 | 2016 |
| Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study H Ibsen, MH Olsen, K Wachtell, K Borch-Johnsen, LH Lindholm, ... Hypertension 45 (2), 198-202, 2005 | 803 | 2005 |
| Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study K Wachtell, H Ibsen, MH Olsen, K Borch-Johnsen, LH Lindholm, ... Annals of internal medicine 139 (11), 901-906, 2003 | 803 | 2003 |
| Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge R Saxena, MF Hivert, C Langenberg, T Tanaka, JS Pankow, ... Nature genetics 42 (2), 142-148, 2010 | 750 | 2010 |
| Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study LH Lindholm, H Ibsen, K Borch-Johnsen, MH Olsen, K Wachtell, B Dahlöf, ... Journal of hypertension 20 (9), 1879-1886, 2002 | 563 | 2002 |
| Risk prediction is improved by adding markers of subclinical organ damage to SCORE T Sehestedt, J Jeppesen, TW Hansen, K Wachtell, H Ibsen, ... European heart journal 31 (7), 883-891, 2010 | 508 | 2010 |
| Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population J Eugen‐Olsen, O Andersen, A Linneberg, S Ladelund, TW Hansen, ... Journal of internal medicine 268 (3), 296-308, 2010 | 413 | 2010 |
| May Measurement Month 2017: an analysis of blood pressure screening results worldwide T Beaney, AE Schutte, M Tomaszewski, C Ariti, LM Burrell, RR Castillo, ... The Lancet Global Health 6 (7), e736-e743, 2018 | 364 | 2018 |
| Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE … K Wachtell, B Hornestam, M Lehto, DJ Slotwiner, E Gerdts, MH Olsen, ... Journal of the American College of Cardiology 45 (5), 705-711, 2005 | 339 | 2005 |
| Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study K Wachtell, PM Okin, MH Olsen, B Dahlöf, RB Devereux, H Ibsen, ... Circulation 116 (7), 700-705, 2007 | 322 | 2007 |
| Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients P Willeit, L Tschiderer, E Allara, K Reuber, L Seekircher, LU Gao, X Liao, ... Circulation 142 (7), 621-642, 2020 | 308 | 2020 |
| Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure J Redon, MH Olsen, RS Cooper, O Zurriaga, MA Martinez-Beneito, ... European heart journal 32 (11), 1424-1431, 2011 | 289 | 2011 |
| May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension T Beaney, LM Burrell, RR Castillo, FJ Charchar, S Cro, A Damasceno, ... European heart journal 40 (25), 2006-2017, 2019 | 257 | 2019 |
| Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study K Wachtell, MH Olsen, B Dahlöf, RB Devereux, SE Kjeldsen, ... Journal of hypertension 20 (3), 405-412, 2002 | 246 | 2002 |
